Réf :HematoStat.net ; 2 (3) : V43   The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cellymphoma https://doi.org/10.1016/j.annonc.2021.12.002  

Réf :HematoStat.net ; 2 (3) : V42   Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study. […]

Réf :HematoStat.net ; 2 (1) : V41   Tanya T Mararand al.Thrombin spatial distribution determines Protein C activation during hemostasis and thrombosis. Blood. 2021 Dec 10;blood.2021014338. doi: 10.1182/blood.2021014338 PMID: 34890454

Réf :HematoStat.net ; 2 (1) : V40 Marco Zuin and al.Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis. Thromb Res. 2022 Jan;209:94-98.doi: […]

Réf :HematoStat.net ; 2 (1) : V39   Anna Collins and al.The risk of venous thromboembolism in early pregnancy loss: Review of the literature and current guidelines and the need […]

Réf :HematoStat.net ; 2 (1) : V38 Matteo Nicola Dario Di Minnoand al. Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of […]

Réf :HematoStat.net ; 2 (1) : V37 Jenny Klintmanand al.Bone mineral density in haemophilia – a multicentre study evaluating the impact of different replacement regimens. Haemophilia. 2022 Jan 7.  doi: […]